Show Search Form

Search Results

human indexable	true false
published	true false
registered interest	true false
answer date	exactly: or between: and
date	exactly: or between: and
date tabled	exactly: or between: and
ddp created	exactly: or between: and
answering body
question status
answering dept id
answering dept short name
answering dept sort name
ddp modified
hansard heading
house id
identifier
legislature
parliament number
question first answered
question text
session
session number
tabling member constituency
tabling member printed
title
type
uin
version
written parliamentary question type
answer	answer text question first answered
creator	label
publisher
tabling member	label

Search

1133134

	human indexable
	published
	registered interest
	answer date	24/06/2019
	date	19/06/2019
	date tabled	19/06/2019
	ddp created	19/06/2019 17:54:08
	answering body	Home Office
	question status	Tabled
	answering dept id	1
	answering dept short name	Home Office
	answering dept sort name	Home Office
	ddp modified	20/06/2019 15:45:10 26/06/2019 15:29:01
	hansard heading	Drugs: Misuse
	house id	1
	identifier	266698
	legislature	25259
	parliament number	57
	question first answered	26/06/2019 14:57:06
	question text	To ask the Secretary of State for the Home Department, what assessment he has made of the effect of the reclassification of (a) pregabalin/Lyrica and (b) other drugs on the sale of drugs on the street.
	session	2017/19
	session number	1
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	title	House of Commons Tabled Parliamentary Question 2017/19 266698
	type	WrittenParliamentaryQuestion
	uin	266698
	version	2
	written parliamentary question type	Ordinary
	answer	answer answer text <p>An impact assessment was published on the gov.uk website prior to the control of pregabalin under Class C of the Misuse of Drugs Act 1971 in April 2019. Impact assessments are routinely prepared prior to the control of substances under the 1971 Act and we regularly meet partners, such as the police, who provide valuable insights into the effect of control on drug markets</p> question first answered 26/06/2019 14:57:06
	creator	4131 label Biography information for Jim Shannon
	publisher	25259
	tabling member	4131 label Biography information for Jim Shannon

1313226

	human indexable
	published
	registered interest
	answer date	13/05/2021
	date	11/05/2021
	date tabled	11/05/2021
	ddp created	11/05/2021 22:03:18
	answering body	Department of Health and Social Care
	question status	Tabled
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	ddp modified	11/05/2021 22:12:40 24/05/2021 10:24:09
	hansard heading	Drugs: Misuse
	house id	1
	identifier	240
	legislature	25259
	parliament number	58
	question first answered	24/05/2021 09:52:17
	question text	To ask the Secretary of State for Health and Social Care, what steps he is taking with social media platforms to ensure that appropriate warnings are provided on such platforms on unlicensed weight gain drugs such as apetamin.
	session	2021/22
	session number	2
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	title	House of Commons Tabled Parliamentary Question 2021/22 240
	type	WrittenParliamentaryQuestion
	uin	240
	version	1
	written parliamentary question type	Ordinary
	answer	answer answer text <p>Apetamin is considered to be a medicinal product and requires a Marketing Authorisation or product licence to be legally sold and supplied within the United Kingdom. A Marketing Authorisation guarantees the medicine has met required standards of quality, safety and efficacy. No authorisations or licences have been granted for Apetamin and consequently offers to sell or supply it are in breach of UK legal requirements.</p><p>The Medicines and Healthcare products Regulatory Agency issues regular warnings to the public concerning the risks of purchasing from unregulated websites and has run a targeted public awareness campaign #FakeMeds across social media which provided detail and tips to purchase medicines online safely.</p> question first answered 24/05/2021 09:52:17
	creator	4131 label Biography information for Jim Shannon
	publisher	25259
	tabling member	4131 label Biography information for Jim Shannon

1382831

	human indexable
	published
	registered interest
	answer date	01/12/2021
	date	29/11/2021
	date tabled	29/11/2021
	ddp created	29/11/2021 20:56:45
	answering body	Home Office
	question status	Tabled
	answering dept id	1
	answering dept short name	Home Office
	answering dept sort name	Home Office
	ddp modified	30/11/2021 14:35:27 10/12/2021 14:36:08
	hansard heading	Drugs: Misuse
	house id	1
	identifier	83379
	legislature	25259
	parliament number	58
	question first answered	10/12/2021 14:05:12
	question text	To ask the Secretary of State for the Home Department, what steps she is taking to reduce the use of GHB drugs in the UK.
	session	2021/22
	session number	2
	tabling member constituency	Strangford
	tabling member printed	Jim Shannon
	title	House of Commons Tabled Parliamentary Question 2021/22 83379
	type	WrittenParliamentaryQuestion
	uin	83379
	version	2
	written parliamentary question type	Ordinary
	answer	answer answer text <p>GHB (gamma-Hydroxybutyric acid) is controlled under Class C of the Misuse of Drugs Act 1971 and scheduled under Schedule 2 of the Misuse of Drugs Regulations 2001 (the 2001 Regulations). Two related substances, gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) are also controlled under Class C of the Misuse of Drugs Act 1971.</p><p>In March 2021, following recommendations by the independent Advisory Council on the Misuse of Drugs (ACMD), the Home Secretary announced the tightening of restrictions around the drugs GHB, GBL and 1,4-BD. In line with the ACMD’s advice, these drugs will, subject to Parliamentary approval, be moved from Class C to Class B under the Misuse of Drugs Act 1971.</p><p>The maximum penalty for the possession of a Class C drug is up to 2 years in prison, an unlimited fine, or both. The maximum penalty for the possession of a Class B drug is 5 years in prison, an unlimited fine, or both. In addition, the Home Secretary agreed to the ACMD’s recommendation to place GBL and 1,4-BD in Schedule 1 to the 2001 Regulations and remove the exemption that makes it lawful to import, export, produce, supply, offer to supply or possess GBL and 1,4-BD in certain circumstances, so that those who possess them for legitimate industrial purposes will require a licence to do so. The Government intends to bring forward legislation shortly.</p> question first answered 10/12/2021 14:05:12
	creator	4131 label Biography information for Jim Shannon
	publisher	25259
	tabling member	4131 label Biography information for Jim Shannon